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Effect of dialysis and renal transplantation on autonomic dysfunction in
chronic renal failure. Autonomic functions were evaluated in 25 nondi-
alyzed patients with chronic renal failure and eight controls. Eight
patients were reassessed after 6.6 1.0 weks of hemodialysis and 12
patients were restudied 24 4.0 weeks after renal transplantation. In
addition, six patients who had been on maintenance hemodialysis for a
duration of 21.5 3.0 weeks were also studied. Autonomic function
tests, including blood pressure and heart rate response to sudden loud
noise, mental arithmetic, hand immersion in cold water, Valsalva
maneuver, change in posture and respiration, were performed using
brachial artery cannulation and continuous monitoring by electrocar-
diogram. Baroreceptor sensitivity slope was determined using bolus
injections of phenylephrine. Supine and standing plasma norepineph-
rine levels were measured. The cold pressor test, response to sudden
loud noise and mental arithmetic were normal in nondialyzed patients
with chronic renal failure, suggesting an intact efferent sympathetic
pathway. The plasma norepinephrine concentration varied widely but
the mean value was similar to the control group (P > 0.05). Expiration!
inspiration ratio, lying!standing ratio, Valsalva ratio and the barorecep-
tar sensitivity slope were significantly abnormal (P < 0.001) in nondi-
alyzed patients. This indicates a defective efferent parasympathetic
pathway and depressed baroreceptor sensitivity. The blood pressure
response to phenylephrine was lower in the uremics, suggesting a
reduced end-organ responsiveness to alpha agonists. The presence of
hypertension did not affect autonomic function. The heart rate response
to standing and the baroreceptor sensitivity were significantly lower (P
< 0.05) in patients who developed hypotension during hemodialysis.
Lower barorefiex sensitivity could contribute to hypotension during
dialysis. Autonomic functions remained unaltered after short- and
long-term dialysis. Following renal transplantation significant reversal
of autonomic dysfunction was observed (P < 0.02).
With the advent of maintenance hemodialysis and the conse-
quent increase in the longevity of patients with chronic renal
failure, disturbances of the autonomic nervous system are being
encountered with greater frequency. Several authors have
shown involvement of the autonomic nervous system in chronic
renal failure [1—101. Dialysis related hypotension is suggested to
be the result of autonornic insufficiency [11—141. The etiological
factors incriminated in uremic autonomic neuropathy include
antihypertensive therapy, the uremic state and underlying dis-
eases such as diabetes mellitus and amyloidosis [4].
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Controversy exists regarding the site of lesion in the sympa-
thetic and parasympathetic pathways. Some investigators [15]
have postulated that the lesion may reside in the baroreceptors.
Others [14] have implicated an abnormal baroreceptor or af-
ferent limb, while some [7] have demonstrated a defective
cardiac efferent parasympathetic pathway. In addition, the
efficacy of hemodialysis in ameliorating the abnormalities in the
autonomic nervous system has been a subject of considerable
debate. There are also no published data on the effect of
hemodialysis and renal transplantation on the autonomic func-
tions of the same patients with chronic renal failure. In this
study, we have investigated the autonomic functions in twenty-
five patients with chronic renal failure who had never received
any dialysis. Eight were restudied after short-term hemodialysis
and twelve were reassessed after successful renal transplanta-
tion. In addition, six patients on long-term hemodialysis were
also studied.
Methods
Patients
The study was carried out on twenty-five nondialyzed pa-
tients with chronic renal failure (males 20, females 5, age 28.5
1.6 years) with a serum creatinine more than 8 mg/dl (11.6
0.6). Hematocrit was 23.8 3.0%. Patients with diabetes
mellitus, reversible renal failure, cardiac arrhythmias, pericar-
dial effusion, emphysema, cardiac failure and prolonged bed
rest were excluded. Chronic renal failure was due to chronic
glomerulonephritis in 15, chronic interstitial nephritis in 8,
polycystic kidney disease and vesicoureteral reflux in 1 each.
Of the 25 patients studied, 22 entered the chronic dialysis
program awaiting renal transplantation. Eight of these patients
were restudied after they had received hemodialysis for a
duration ranging from 4 to 10 weeks (6.6 1.0 weeks). Six
additional patients (males 5, females I, age 33.2 5.0 years)
who were on long-term hemodialysis for a duration of 21.5
3.0 weeks (range 14 to 35) were also studied. The cause of
chronic renal failure was chronic glomerulonephritis in three,
polycystic kidney disease, Alport's syndrome and chronic
interstitial nephritis in one each. The predlalysis autonomic
status of these patients was not evaluated. Hemodialysis was
carried out twice weekly for four hours each, using a hollow-
fiber cuprophane dialyzer. The biochemical parameters of the
patients restudied after dialysis is shown in Table 1. Fourteen
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a p < 0.05 (1 vs. 2)
b p < 0.05 (1 vs. 3)
Expiration/inspiration ratio
Supine/standing ratio
Valsalva maneuver
Baroreflex sensitivity
Cold pressor test
Response to mental arithmetic
Response to loud noise
Plasma norepinephrine
(supine and standing)
Table 1. Biochemical parameters of patients with chronic renal
failure
Short-term dialysis (N = 8) Long-term
dialysis
.
Before (I) After (2) (N = 6) (3)
Hematocrit % 22.0 1.02 22.88 1.02 25.33 1.12
Serum creatinine 11.8 1.09 6.06 0.33° 6.57 0.21''
mg/dl
Blood urea 145.6 11.34 115.5 10.95a 110 82b
mg/dl
Table 2. List of the autonomic function tests performed and the
pathway examined by each
Test Part of reflex arc tested
Efferent parasympathetic pathway
Efferent parasympathetic pathway
High and low pressure baroreceptors,
afferent and efferent sympathetic
and parasympathetic pathways
Postural fall of blood pressure Afferent and efferent limbs
(parasympathetic and sympathetic)
Baroreceptors, afferent and efferent
parasympathetic pathway
Efferent sympathetic pathway
Efferent sympathetic pathway
Efferent sympathetic pathway
Efferent sympathetic pathway
patients subsequently underwent living-related renal transplan
tation. One patient died of septicemia two months following
transplantation and one patient was lost to follow-up. The
remaining twelve patients were reassessed 24 4.0 weeks
(range 12 to 56) following renal transplantation. These patients
were on immunosuppressive therapy consisting of cyclosporin
A, azathioprine and prednisone. The post-transplant serum
creatinine was 1.5 0.1 mg/dl. Hematocrit was 39.42 1.12%.
Eight normal subjects (31.7 4.2 years) served as controls. All
patients gave a written informed consent to the study and the
protocol was approved by the hospital ethical committee.
Protocol
The investigations were performed as an out-patient proce-
dure. An intravenous cannula was inserted into an arm vein and
kept heparinized. The left brachial artery was cannulated
percutaneously using a 1 mm teflon cannula (Seldicath). Intra-
arterial pressure was monitored on a Hewlett Packard pressure
monitor and recorded on a 4 channel Siemens mingograf
recorder along with lead II of the electrocardiogram and respi-
ration. Antihypertensive drugs were discontinued at least one
week prior to the study.
Autonomic functions tests
A list of autonomic functions tested and the site of the
autonomic pathway subserved by them is shown in Table 2
[16—19]. Expiration/inspiration (E/I) ratio was calculated by
observing the mean of the longest RR interval during expiration
divided by the mean of the shortest RR interval during inspira-
tion while the patient took six deep breaths per minute. Cold
pressor test was carried out by immersing one hand of the
patient into water at 4°C for one minute and the ensuing rise in
blood pressure recorded. Valsalva maneuver was performed by
making the patient blow against a mercury column for 15
seconds to maintain a pressure of 40 mm Hg. During the
maneuver, the intraarterial blood pressure, electrocardiogram
and respiration were continuously recorded. The Valsalva ratio
was calculated by dividing the longest RR interval during phase
IV by the shortest RR interval during phase II. Baroreceptor
sensitivity slope was assessed by giving an intravenous bolus of
phenylephrine (25 to 50 j.tg) and recording the increase in blood
pressure and decrease in heart rate at a paper speed of 25
mm/sec. The slope was computed using a statistical package,
Microstat (Ecosoft Inc., USA), plotting the systolic blood
pressure of every beat against the subsequent RR interval and
expressed as msec/mm Hg.
The effect of mental stress on blood pressure and heart rate
was studied by asking the patient to solve a difficult arithmetic
problem mentally while the heart rate and blood pressure were
continuously recorded. The response of the arterial blood
pressure to sudden loud noise was also recorded. The supine!
standing (L/S) ratio was calculated as the ratio of the RR
interval of the 30th and 15th beat. The first beat being recorded
immediately after the patient stood up from the lying posture.
Postural fall in the systolic blood pressure was recorded as the
difference between the basal supine and standing (after 2 mm)
arterial blood pressures. Samples for plasma norepinephrine
were taken after the patient had been in the supine posture for
30 minutes and then 10 minutes after standing. Plasma norepi-
nephrine was determined by HPLC with electrochemical detec-
tion. The mean within-assay and between-assay coefficient of
variation were 5.7 and 6.8, respectively [201.
Statistical analysis
The data in the text, Tables and Figures are displayed as
mean SEM. Differences between the means were analyzed
using paired and unpaired Student's t-test.
Results
Nondialyzed patients
Four patients had evidence of peripheral neuropathy and one
complained of impotence. None of the patients had any history
of paroxysmal diarrhea or urinary incontinence.
The results of the autonomic function tests are shown in
Tables 3, 4 and 5, and in Figures 1 to 3. The resting heart rate
of the patients was significantly higher (P < 0.05) than the
control group. The average arterial blood pressure was within
the normal range. The E/I ratio was significantly reduced (Fig.
1). However, the ratio was abnormal (l.20) in 21(84%) and
normal (l.21) in 4(16%). Valsalva ratio was normal (1.21) in
17 patients (68%) and abnormal (1.20) in 8 (32%). L/S iatio
was normal ( 1.04) in 7 (28%) patients and abnormal (1.04) in
18 (72%). None of the patients had symptomatic postural
hypotension. Only six patients had a postural fall in systolic
blood pressure of more than 10 mm Hg (average 17.7 1.3).
The baroreceptor sensitivity slope was significantly lower in the
patients than in the control group (Fig. 2). The average dose of
penylephrine required to produce a 20 to 40 mm Hg rise in
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Table 3. Autonomic functions in nondialyzed patients with chronic
renal failure
Patients
(N = 25)
Controls
(N = 8) Pvalue
Basal heart rate beats/mm 84.4 2.0 76 2.8 <0.05
Basal systolic blood pressure 147 4.9 136 6.4 NS
mm Hg
Basal diastolic blood pressure 89 3.4 78 2.1 NS
mm Hg
Expiration/inspiration ratio 1.14 0.02 1.62 0.05 <0.001
Supine/standing ratio 1.03 0.01 1.12 0.01 <0.001
Valsalva ratio 1.34 0.05 1.79 0.06 <0.001
Baroreceptor sensitivity slope 3.88 0.52 11.2 1.1 <0.001
msec/mm Hg
Postural fall mm Hg 6.0 1.5 4.5 1.4 NS
Sudden loud noise
Systolic blood pressure 12.0 1.5 18 4.2 NS
mm Hg
Diastolic blood pressure 6.7 1.0 4 1.1 NS
mm Hg
Cold pressor test
Systolic blood pressure 19 2.8 18 2.1 NS
mm Hg
Diastolic blood pressure 10.2 2.0 10 1.4 NS
mm Hg
Mental arithmetic
Systolic blood pressure 16 1.6 10 1.4 <0.05
mm Hg
Diastolic blood pressure 10.8 1.2 6 1.1 <0.05
mm Hg
Plasma norepinephnne pg/ml
Supine 274.4 65.0 196.6 23.0 NS
Standing 674.1 193.1 346.3 65.8 NS
Data are mean SEM.
blood pressure was no different in the patients (42.4 3.7 g)
and the controls (40.6 4.6 pg). The rise of systolic and
diastolic blood pressures after bolus phenylephrine was signif-
icantly lower in the nondialyzed patients (29.65 2.3 and 10.26
0.97 mm Hg) compared to the rise seen in the controls (41.3
3.53 and 15.71 2.47 mm Hg; P < 0.02). Mental arithmetic
caused an exaggerated response to both systolic and diastolic
pressures in patients as compared to controls. Seventeen pa-
tients (68%) had a rise of more than 10 mm Hg systolic blood
pressure in response to mental arithmetic. No difference was
noted in the blood pressure response to sudden loud noise in
both the groups. Hand immersion in cold water produced a rise
of systolic blood pressure of equal magnitude in both groups.
The basal supine plasma norepinephrine in the patients varied
but the mean value was not different from the control group.
The plasma concentration on standing were also not signifi-
cantly different in the two groups.
Hypertensive and normotensive patients
Among the 25 patients studied, 14 were hypertensive and
were controlled on drugs. All antihypertensive drugs were
discontinued one week prior to the study. The average systolic
and diastolic blood pressures were significantly different in the
two groups (P < 0.001). The remaining 11 patients had never
been documented to have hypertension. There was no signifi-
cant difference in the autonomic functions of both these groups,
except for the heart rate and blood pressure response to
orthostasis. The L!S ratio was 1.05 0.01 in the hypertensive
Table 4. Autonomic functions before and after short-
and long-term (N = 6) dialysis
term (N = 8)
Short-term dialysis Long-term
dialysisBefore After
Basal heart rate 84 4.03 89 3.53 93.3 5.03
beats/mm
Basal systolic blood 156 9.68 156.3 8.9 153 10.7
pressure mm Hg
Basal diastolic blood 94.5 7.77 95.7 5.65 89.3 9.32
pressure mm Hg
Expiration/inspiration 1.14 0.04 1.19 0.05a 1.12 0.02
ratio
Supine/standing ratio 1.06 0.02 1.03 0.01 1.03 0.01
Valsalva ratio 1.33 0.05 1.46 0.09 1.25 0.02
Baroreceptor sensitivity
Slope mseclmm Hg 4.75 0.6 5.3 0.64 4.26 0.88
Postural fall mm Hg 6.7 2.5 8.7 3.96 11 1.0
Sudden loud noise
Systolic blood pressure 13.7 3.36 6.3 1.8 10.2 1.3
mm Hg
Diastolic blood 10.2 1.27 6.5 1.87 6.67 0.88
pressure mm Hg
Cold pressor test
Systolic blood pressure 14.8 2.51 15 1.13 12.67 0.84
mm Hg
Diastolic blood 6.8 2.62 10.2 1.38 7.67 0.62
pressure mm Hg
Mental arithmetic
Systolic blood pressure 14 1.84 10.4 2.08 11.5 1.93
mm Hg
Diastolic blood 12.5 2.01 9.5 1.17 7 1.63
pressure mm Hg
Data are mean SEM.
a P < 0.001 before vs. after
group, compared to 1.01 0.01 in the normotensive group (P <
0.05). The postural fall of systolic blood pressure was signifi-
cantly higher (8.93 2.3 mm Hg) in the hypertensive than in the
normotensive patients (2.18 1.1 mm Hg; P < 0.02).
Effect of hemodialysis
During dialysis ten patients developed hypotensive episodes
defined as a fall in systolic blood pressure below 100 mm Hg on
at least two occasions and were treated on each occasion with
intravenous normal saline. Seven of these patients were hyper-
tensive and the remaining three normotensive. A comparison of
the autonomic functions of patients who developed hypotension
during hemodialysis (N = 10) to those who did not have this
complication (N = 12) was made. The baroreceptor sensitivity
slope was significantly lower in the hypotensive group (3.10
0.84 msec/mm Hg) compared to the normal group (5.32 0.55
msec/mm Hg, P < 0.02; Fig. 2). The L/S ratio was also lower in
this group (1.023 0.009 vs. 1.06 0.018, P <0.05). There was
no significant difference in any of the other parameters.
Eight patients were restudied 6.6 l0 weeks (range 4 to 10
weeks) after regular hemodialysis. Of these eight patients only
three belonged to the group of ten patients who developed
hypotension during dialysis. The El! ratio rose from 1.14 0.04
to 1.19 0.05 (P < 0.OOl)following short-term dialysis and was
the only parameter to change significantly. To test whether
long-term dialysis has any additional effect on the autonomic
function, we investigated another group of six uremic patients
who had been on maintenance dialysis for 21.5 3.0 weeks.
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Table 5. Autonomic functions before and after renal transplantation
(N = 12)
P< 0.001
I 1N= 8
20 —
16 —
12-
E
E
73
CU
U)
E 8—
4—
0—'
Before After P value
Basal heart rate beats/mm 83.7 2.4 82.9 3.2 NS
Basal systolic blood pressure 149.8 6.5 142.4 4.1 NS
mm Hg
Basal diastolic blood pressure 93.4 3.8 89.7 2.0 NS
mm Hg
Expiration/inspiration ratio 1.13 0.02 1.34 0.04 <0.001
Supine/standing ratio 1.046 0.014 1.075 0.01 <0.001
Valsalva ratio 1.37 0.09 1.65 0.08 <0.001
Baroreceptor sensitivity slope 3.95 0.83 7,46 0,56 <0.001
msec/mm Hg
Sudden loud noise
Systolic blood pressure 12.3 2.4 9.6 1.5 NS
mm Hg
Diastolic blood pressure 6 1.5 8 1.6 NS
mm Hg
Cold pressor test
Systolic blood pressure 18.5 3.5 13.3 2.3 NS
mm Hg
Diastolic blood pressure 10.1 1.7 8.6 1.6 NS
mm Hg
Mental arithmetic
Systolic blood pressure 12.3 1.3 10 0.9 NS
mm Hg
Diastolic blood pressure 10.2 1.9 8.5 1.8 NS
mm Hg
Plasma norepinephrine pg/mi
Supine 150.8 61.9 179.3 51.2 NS
Standing 363.0 63.4 347.0 122.2 NS
Data are mean SEM.
N = 25
P<0.02
N = 12
Controls Nondialyzed
patients
Hypotension No
prone hypotension
2.5 -
2-
Fig. 2. Values of baroreceptor sensitivity slope in patients with chronic
renal failure showing significantly lower values in those who subse-
quently developed hypotension during hemodialysis.
P< 0.001
p<0.001
0
CU
2.5
2-
1.5-
1-
0.5 -
P< 0.001
1.5 -
P < 0.001
P < 0.001
Pre Post Pre, Post Pre Post
-12
-8 c
E
• E
13
-0
P< 0.001
0.5
Valsalva ratio
Fig. 1. Comparison of autonomic function tests in nondialyzed pa-
tients with chronic rena/failure () and controls (I).
The results of the autonomic functions on these six patients are
given in Table 4. No difference was seen in the parameters of
these patients when compared to the eight patients who were
studied before and after 6.6 1.0 weeks of dialysis. The plasma
norepinephrine levels were 531 137.6 pg/mI and 822.7 103.4
in the supine and standing postures, respectively, in these six
patients.
ElI ratio Valsalva ratio Baroreflex
sensitivity
Fig. 3. Effect of renal transplantation on parasympathetic function
tests.
Effect of renal transplantation
The effects of renal transplantation in 12 patients reassessed
after successful transplantation is shown in Table 5 and Figure
3. There was a significant reversal of all the abnormal parasym-
pathetic tests following transplantation.
Discussion
Autonomic function tests have been shown to be abnormal in
patients with chronic renal failure [1—10]. However, no system-
atic study has yet been made to localize the site and elucidate
the precise mechanisms responsible for these abnormalities.
Furthermore, there are no studies on patients with chronic renal
failure before and after hemodialysis or following renal trans-
plantation. In this paper we report a systematic study using a
number of tests of autonomic functions in the same patients,
before and after hemodialysis and renal transplantation.
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Sympathetic function
The cold pressor test and blood pressure response to loud
noise were normal. Mental arithmetic caused an exaggerated
blood pressure response. None of the patients had significant
postural hypotension. The plasma norepinephrine concentra-
tion in our patients varied widely (supine 88 to 728 pg/mI and
standing 180 to 2040 pg/mI). The average plasma concentration
was, however, within the normal range, both in the supine and
standing postures. Norepinephrine levels in patients with
chronic renal failure have been reported to be low [21], normal
[22] or high [9, 23—25]. The higher plasma norepinephrine level
seen in some of our patients and those reported in literature,
might be due to an increased release from the synaptic cleft,
reduced re-uptake into nerves, reduced clearance or decreased
enzymatic degradation [23, 26]. The data on sympathetic tests
therefore, suggest an intact efferent sympathetic pathway.
Parasympathetic function
All the parasympathetic function tests studied in the nondia-
lyzed patients were found to be abnormal. Similar abnormalities
have also been reported earlier in the literature [3, 7, 10, 27].
The El! ratio is a good index of cardiac efferent parasympa-
thetic function [8]. This was significantly reduced in nondia-
lyzed patients with chronic renal failure but improved signifi-
cantly after dialysis, although the ratio did not revert entirely to
normal. The LIS ratio, Valsalva ratio and the baroreceptor
sensitivity slope were also significantly abnormal in the nondi-
alyzed patients. Short- or long-term hemodialysis did not sig-
nificantly affect these parameters. The LIS ratio is also an index
of efferent cardiac parasympathetic control and vagal injury or
blockade results in an abnormal L/S ratio. The Valsalva ma-
neuver examines the integrity of the entire autonomic arc, that
is, both high and low pressure baroreceptors, afferent and
efferent sympathetic and parasympathetic pathways. Abnor-
mality in the heart rate response during the phase IV could be
due to failure of the blood pressure to rise secondary to an
inappropriate change in peripheral vascular resistance or to
derangement in the vagal efferent pathway. The rise in blood
pressure during phase IV is due to an increase in peripheral
vascular resistance produced by augmented sympathetic activ-
ity and an increase in stroke volume secondary to an enhanced
venous return [28]. In our patients, although the overshoot in
the blood pressure during phase IV of the Valsalva maneuver
was normal (indicating a normal sympathetic response), the
Valsalva ratio was abnormal. This was due to an abnormal
slowing of the heart rate in response to the rise in the blood
pressure, suggesting an abnormal vagal or parasympathetic
pathway.
The baroreceptor sensitivity slope was significantly de-
pressed in the nondialyzed patients of chronic renal failure,
similar to the previous observations [5, 27, 29]. Pickering,
Gribbon and Oliver [5] have demonstrated depressed barore-
ceptor activity in chronic renal failure which was more severe in
older patients and in those with a higher blood pressure.
Long-term hemodialysis improved baroreflex sensitivity in five
of their patients. Lazarus Ct al [29] reported depressed barore-
ceptor sensitivity which was lower in hypertensives than in
normotensive uremic patients. No significant difference was
seen in the baroreceptor sensitivity in our hypertensive or
normotensive patients. Hemodialysis did not alter the barore-
ceptor sensitivity slope. The slope was also low in the patients
on long-term dialysis. The blunted heart rate response to blood
pressure elevation by phenylephrine would localize the defect
to the baroreflex arc (baroreceptors, afferent or efferent para-
sympathetic connections). The cause of depressed baroreceptor
activity has been attributed to multiple factors like autonomic
neuropathy, chronic hypertension, heart failure, anemia and
change in arterial distensibility [5, 29]. In this study, no attempt
was made to correlate the baroreceptor sensitivity to the degree
of anemia and none of the patients were in heart failure. The
most plausible explanation for the depressed baroreceptor
sensitivity appears to be a defect in the efferent parasympa-
thetic pathway of the barorefiex arc. This is consistent with the
defective efferent parasympathetic pathway noticed in the
Valsalva maneuver.
Hypotension during hemodialysis
Ten patients had documented hypotension during hemodial-
ysis which responded to infusion of normal saline. Seven of
these patients were hypertensives but their antihypertensive
drugs were omitted on the morning of dialysis. These hypoten-
sion prone patients had a significantly (P < 0.02) lower barore-
ceptor sensitivity slope and L/S ratio (P < 0.05) when compared
to those who did not develop hypotension during dialysis. All
the other parameters were abnormal to the same extent in these
two groups. A lower baroreflex sensitivity seen in the hypoten-
sive patients could accentuate hypotension seen during hemo-
dialysis; a fall in blood pressure would evoke a smaller increase
in heart rate if the barorefiex slope was depressed, resulting in
a smaller increase in cardiac output and hence the blood
pressure. Other studies have also reported evidence of barore-
ceptor dysfunction in patients with frequent hypotension during
hemodialysis [15, 25, 27]. Antihypertensive drugs could con-
tribute to hypotension during dialysis.
End-organ responsiveness
Controversy exists regarding the presence or absence of
end-organ responsiveness to catecholamines in patients of
chronic renal failure [7, 8, 11, 26]. In this study, small doses
(42.4 3.7 sg) of the alpha agonist, phenylephrine, similar to
that used in controls (40.6 4.6 tg) caused a 29.7 2.3 and
10.26 0.97 mm Hg rise in systolic and diastolic blood
pressures in patients with chronic renal failure and 41.3 3.5
and 15.71 2.47 mm Hg, respectively, in the controls, suggest-
ing a reduced end-organ responsiveness to the alpha agonist,
phenylephrine (P < 0.02). This is unlike the experience in
patients with chronic constrictive pericarditis, where doses as
high as 548 48 g fail to cause a significant rise in the blood
pressure [30]. The rise in the systolic and diastolic blood
pressure was also lower in the eight patients studied before and
after short-term hemodialysis (27.5 3.6/11.6 1.5 and 27.6
3.3/12.5 1.1 mm Hg). The rise of blood pressure (systolic and
diastolic) in the six patients on long-term dialysis was 31.7 4.6
and 15.4 2.2 mm Hg, and was not significantly different from
the increment seen in the nondialyzed patients. Following renal
transplantation the pressor response to phenylephrine was
significantly higher and comparable to the control group (43.6
2.0 mm Hg; P <0.001). The normal increase in blood pressure
in phase IV of the Valsalva maneuver seen in our patients also
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indirectly excluded significant down regulation of alpha recep-
tors. No attempt was made to study beta receptor responsive-
ness.
The etiology of autonomic dysfunction in uremic patients
remains unclear. A "uremic toxin" has been suggested to be
responsible for autonomic dysfunction since improvement has
been noted after dialysis [5, 31]. However, we and some other
investigators [32] have found no change in the autonomic
functions after dialysis, and hence the role of this toxin remains
conjectural. The plasma level of the water soluble vitamin B12
is low in patients with chronic renal failure due to loss during
hemodialysis. Remarkable improvement in the autonomic func-
tion has been documented three to six months following oral
supplementation with mecobalamin (an analog of vitamin B 12)
1500 ig per day [33, 34]. There are other reports which have not
shown any significant difference between the vitamin B12 levels
between healthy controls [35] and patients with chronic renal
failure before and after hemodialysis [36].
Renal transplantation
Renal transplantation reverses most of the complications of
uremia, Normalization of all abnormal autonomic parameters
were seen in our patients as early as three months following
renal transplantation. This has never been reported earlier.
Previous studies have compared autonomic functions in sepa-
rate groups of patients, that is, pre-dialysis, after dialysis and in
renal transplant recipients [32, 331.
In conclusion, this study has shown that autonomic dysfunc-
tion exists in nondialyzed patients who have chronic renal
failure. This derangement is localized mainly to the cardiac
efferent parasympathetic pathway. The efferent sympathetic
pathways are intact. End-organ responsiveness is reduced. The
presence of hypertension complicating chronic renal failure
does not affect autonomic functions. The baroreceptor sensitiv-
ity is more depressed in the patients prone to hypotension
during dialysis, which may accentuate the hypotension. Short-
term (6.6 1.0) or long-term (21.5 3.0 weeks) hemodialysis
does not significantly alter the autonomic function, but renal
transplantation results in complete normalization of autonomic
dysfunction.
Reprint requests to Professor KS. Chug/i, Department of Nephrol-
ogy, Postgraduate Institute of Medical Education and Research, C/ian-
digarh, /60012, India.
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